News Releases

Date Title  
06/30/22
TORONTO , June 30, 2022 (GLOBE NEWSWIRE) -- Venus Concept Inc. (“Venus Concept” or the “Company”) (NASDAQ: VERO), a global medical aesthetic technology leader, announced today that second quarter of fiscal year 2022 financial results will be released before the market opens on Friday, August 12,
05/12/22
TORONTO , May 12, 2022 (GLOBE NEWSWIRE) -- Venus Concept Inc. (“Venus Concept” or the “Company”) (NASDAQ: VERO), a global medical aesthetic technology leader, announced financial results for the three months ended March 31, 2022 . First Quarter 2022 Summary & Recent Highlights: Total revenue of
04/28/22
Clearance Expands Indications for Use to Include Non-Invasive Lipolysis of the Back and Thighs and Increases Maximum Energy Output to 150 Watts TORONTO , April 28, 2022 (GLOBE NEWSWIRE) -- Venus Concept Inc. (“ Venus Concept” or the “Company”) (NASDAQ: VERO), a global medical aesthetic technology
04/25/22
TORONTO , April 25, 2022 (GLOBE NEWSWIRE) -- Venus Concept Inc. (“ Venus Concept” or the “Company”) (NASDAQ: VERO), a global medical aesthetic technology leader, today announced that the first patient has been treated in a U.S. Investigational Device Exemption (IDE) clinical study evaluating the
04/04/22
TORONTO , April 04, 2022 (GLOBE NEWSWIRE) -- Venus Concept Inc. (“ Venus Concept” or the “Company”) (NASDAQ: VERO), a global medical aesthetic technology leader, announced today that first quarter of fiscal year 2022 financial results will be released after the market closes on Thursday, May 12,
03/31/22
TORONTO , March 31, 2022 (GLOBE NEWSWIRE) -- Venus Concept Inc. (“ Venus Concept” or the “Company”) (NASDAQ: VERO), a global medical aesthetic technology leader, today announced it has submitted a 510(k) premarket notification (“510(k)”) to the U.S. Food and Drug Administration ("FDA"), which is
03/28/22
TORONTO , March 28, 2022 (GLOBE NEWSWIRE) -- Venus Concept Inc. (“ Venus Concept” or the “Company”) (NASDAQ: VERO), a global medical aesthetic technology leader, announced financial results for the three and twelve months ended December 31, 2021 . Fourth Quarter 2021 Summary & Recent Highlights:
03/21/22
TORONTO , March 21, 2022 (GLOBE NEWSWIRE) -- Venus Concept Inc. (“ Venus Concept” or the “Company”)  (NASDAQ: VERO), a global medical aesthetic technology leader, today announced that management will present at the Maxim Virtual Growth Conference , which is being held virtually from March 28th-30th
02/08/22
TORONTO , Feb. 08, 2022 (GLOBE NEWSWIRE) -- Venus Concept Inc. (“ Venus Concept” or the “Company”)  (NASDAQ: VERO), a global medical aesthetic technology leader, today announced that management will participate in the BTIG Virtual MedTech, Digital Health , Life Science & Diagnostic Tools Conference
02/02/22
TORONTO , Feb. 02, 2022 (GLOBE NEWSWIRE) -- Venus Concept Inc. (“ Venus Concept” or the “Company”) (NASDAQ: VERO), a global medical aesthetic technology leader, announced today that fourth quarter and fiscal year 2022 financial results will be released before the market opens on Monday, March 28,
01/18/22
TORONTO , Jan. 18, 2022 (GLOBE NEWSWIRE) -- Venus Concept Inc. (“ Venus Concept” or the “Company”) (NASDAQ: VERO), a global medical aesthetic technology leader, announced today that it has received 510(k) clearance from the U.S. Food and Drug Administration (“FDA”) to market the Venus BlissMAX
01/10/22
TORONTO , Jan. 10, 2022 (GLOBE NEWSWIRE) -- Venus Concept Inc. (“ Venus Concept” or the “Company”) (NASDAQ: VERO), a global medical aesthetic technology leader, today reported preliminary unaudited revenue results for the three months ended December 31, 2021 .